Disclosure Update: Recognition of Extraordinary Gain Due to Completion of Share Transfer with Change to Subsidiaries (Divestiture of Select Overseas Studios & IP)
SQUARE ENIX HOLDINGS CO., LTD. (the "Company") announced in an August 26, 2022 release entitled "Completion of Share Transfer with Change to Subsidiaries (Divestiture of Select Overseas Studios & IP)" that the relevant transfer of shares had been completed.
The present release is to announce the Company's expectation to recognize an extraordinary gain.
1. Recognition of an extraordinary gain
In the three-month period ending September 30, 2022, the Company expects to recognize a gain of about 10billion yen on its sale of shares in affiliated companies. This value for the extraordinary gain is based on information presently available to the Company and may change going forward based on a variety of factors.
2. Future outlook
Because further assessment is required, the Company finds calculating reasonable forecasts of its earnings for the fiscal year ending March 31, 2023 difficult at present and therefore leaves them undetermined.
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from the first and largest real-world patient cohort review...
Smart Meter, the leading supplier of Cellular Remote Patient Monitoring (RPM)tm solutions, has introduced a new version of the iGlucose, its patented cellular-connected glucose meter used by over 200,000 people with diabetes since 2019. The...
F5 announced that it has been singled out as a visionary in API security for its F5 Distributed Cloud Web App and API Protection (WAAP) in Enterprise Management Associates' Vendor Vision 2024 report. The report highlights "must see" security...
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...
Elbit Systems Ltd. ("Elbit Systems" or the "Company") announced today that it was awarded an initial contract of approximately $37 million to supply Iron Fist Active Protection Systems (APS) to General Dynamics Ordnance and Tactical Systems...
